A subscription to JoVE is required to view this content.

English

6.8 : Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.

Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.

Separation of the aromatic ring and amino group: A two-carbon chain optimally separates the amino group from the ring, as seen in norepinephrine and epinephrine.

Substitutions on the amino, α, and β-carbon: Modifications on the amino group and α-carbon affect potency, selectivity, and duration of action. α-methyl substitution increases α1-receptor selectivity. Substituting the amino group with a bulkier alkyl group increases β2-selectivity.

Optical Isomerism: Optical isomers of adrenergic agonists have different pharmacological properties. Levorotatory β-hydroxyl and dextrorotatory α-methyl substitutions exhibit maximum agonist potency.

Understanding the SAR of adrenergic agonists is crucial for developing targeted and effective medications with specific receptor affinity and selectivity.

From Chapter 6:

article

Now Playing

6.8 : Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.4K Views

article

6.1 : Adrenergic Neurons: Neurotransmission

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

3.2K Views

article

6.2 : Adrenergic Receptors (Adrenoceptors): Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

2.0K Views

article

6.3 : Adrenergic Receptors: ɑ Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.3K Views

article

6.4 : Adrenergic Receptors: β Subtype

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Views

article

6.5 : Adrenergic Agonists: Direct-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.2K Views

article

6.6 : Adrenergic Agonists: Indirect-Acting Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

1.4K Views

article

6.7 : Adrenergic Agonists: Mixed-Action Agents

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

600 Views

article

6.9 : Adrenergic Agonists: Therapeutic Classification

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

606 Views

article

6.10 : Adrenergic Agonists: Therapeutic Uses

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

668 Views

article

6.11 : Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

726 Views

article

6.12 : Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

496 Views

article

6.13 : Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

433 Views

article

6.14 : Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

467 Views

article

6.15 : Adrenergic Antagonists: ɑ and β-Receptor Blockers

Drugs Acting on Autonomic Nervous System: Adrenergic Agonists and Antagonists Agents

370 Views

See More

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More